Home › Funds › DDFG, Inc › TTRX

DDFG, Inc position in TTRX

TURN THERAPEUTICS INC · Health Care

DDFG, Inc reported holding 111,379 shares of TTRX (TURN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.32% of its reported portfolio and ranking #36 among its reported holdings. DDFG, Inc has disclosed TTRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)111.38K sh
Reported value held$1.60M
Portfolio Weight0.32%
First reportedQ4 2025
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How DDFG, Inc's TTRX position evolved

DDFG, Inc first disclosed a stake in TTRX in Q4 2025 at 52,288 shares (US$206K). The position peaked in Q3 2026 at 111,379 shares, worth US$1.6M. Across 4 filings, DDFG, Inc increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 111,379 shares valued at US$1.6M — an increase of 3,550 shares quarter over quarter.. Notable position changes include a 35% increase in Q1 2026 (shares rose 128% over the following quarter), a 53% increase in Q2 2026 (shares rose 97% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 52.29K $206.01K New
Q1 2026 70.53K $225.71K Add
Q2 2026 107.83K $787.15K Add
Q3 2026 111.38K $1.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TTRX and 13F data

TTRX (TURN THERAPEUTICS INC) is a Health Care company. 31 other funds we track also report a position in TTRX — the largest reported positions include McCarthy Asset Management, Inc. (US$216K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TTRX

All TTRX fund holders →

FAQ

How long has DDFG, Inc held TTRX?

DDFG, Inc has disclosed TTRX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is DDFG, Inc's current position in TTRX?

As of Q3 2026, DDFG, Inc holds 111.38K shares of TTRX (TURN THERAPEUTICS INC), valued at $1.60M, representing 0.32% of its reported portfolio and ranking #36.

Has DDFG, Inc been buying or selling TTRX?

In the latest 13F filing (Q3 2026), DDFG, Inc increased its position in TTRX. The position peaked in Q3 2026 at 111.38K shares.

Which other funds hold TTRX?

Other major institutional holders of TTRX include McCarthy Asset Management, Inc., among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.